|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016', provides in depth analysis on Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) targeted pipeline therapeutics. The report provides...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016', provides in depth analysis on Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) targeted pipeline therapeutics. The report provides comprehensive information...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016', provides in depth analysis on Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) targeted pipeline therapeutics. The report provides comprehensive...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2016', provides in depth analysis on Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted pipeline therapeutics. The report provides comprehensive...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) The global flow diversion aneurysm treatment market is driven by several factors that include the increase in the incidence of brain aneurysm, increase in demand for minimally invasive endovascular surgeries, and advances in technology. However, challenges...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2016Report SummaryPublisher's, 'Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2016', provides in depth analysis on...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016', provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline therapeutics. The report...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016', provides in depth analysis on Human Papillomavirus Protein E6 (E6) targeted pipeline therapeutics. The report provides comprehensive information on the Human Papillomavirus Protein...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H2 2016SummaryPublisher's, 'Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H2 2016', provides in depth analysis on...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, 'Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016', provides in depth analysis on Hepatitis B Virus Core Antigen (HBcAg) targeted pipeline therapeutics. The report provides comprehensive information on the Hepatitis B Virus...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016SummaryPublisher's, 'Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016', provides in depth analysis on Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted...
Source: EmailWire.com
 (Medical-NewsWire.com, November 11, 2016 ) According to a new market research report "Health IT Security Market Products and Services (Products (Antivirus, IAM, DLP), Services (Consulting, MSS)), Application (Network Security, Endpoint Security), Delivery Mode (On-premise, On-demand), End User (Provider,...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) Publisher's, "Transforming Growth Factor Beta (TGFb) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Transforming Growth Factor Beta (TGFb) Inhibitors. The Publisher's...
Source: EmailWire.com
 (Medical-NewsWire.com, November 10, 2016 ) DelveInsight's Report, "Thrombocythaemia Myelofibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
Source: EmailWire.com
 (Medical-NewsWire.com, November 11, 2016 ) Future Market Insights (FMI), in its latest report titled ‘Contrast Media Injectors Market: Global Industry Assessment and Forecast, 2015-2025’, has projected the global contrast media injectors market revenue to expand at a CAGR of 5.6% during the forecast...
Source: EmailWire.com
|
|
|
|
